By proceeding, you agree to our Terms of Use and Privacy Policy.
Petrina Kamya, PhD, is the Head of AI Platforms for Insilico Medicine, overseeing the business development of Insilico’s end-to-end AI-driven drug discovery platform, Pharma.AI, which includes novel target discovery (PandaOmics), novel small molecule generation (Chemistry42) and clinical trial outcomes prediction (inClinico). Prior to joining Insilico, Dr. Kamya was at Chemical Computing Group where she led sales and business development of molecular modeling software for pharma and biotech companies and then transitioned to a Market Access at Certara where she consulted for pharma companies. She holds a BS in biochemistry and a PhD in chemistry.
Talks About #drugdesign #smallmoleculediscovery #proteinengineering #biologics
Preferred Locations #NorthAmerica